Skip to main content

New Products

  • Nicole by OPI launches Selena Gomez gift sets for holiday

    NEW YORK — Nicole by OPI has launched for the holiday season two new gift sets featuring nail lacquers inspired by actress and singer Selena Gomez.

  • Natural sunscreen maker MelanSol looks to expand availability across U.S.

    BOCA RATON, Fla. — MelanSol, an all-natural sunscreen brand, has announced that it is working to expand the availability of its products across the United States.

  • Actavis seeks approval for generic acne drug

    DUBLIN — Actavis hopes to become the first company to market a generic version of a drug used to treat acne in adolescents and adults, the company said.

    The drug maker announced that it had filed a regulatory approval application with the Food and Drug Administration for a generic version of Acanya (clindamycin phosphate; benzoyl peroxide) gel in the 1.2%/2.5% strength. Acanya is made by Valeant Pharmaceuticals International and Dow Pharmaceutical Sciences and is used to treat acne vulgaris in patients aged 12 and older.

  • Reports: Takeda sues Amneal over generic version of Colcrys

    NEW YORK — Generic drug maker Amneal Pharmaceuticals is seeking Food and Drug Administration approval for a gout drug, prompting a lawsuit from the maker of the branded version, according to published reports.

    Law360 reported that Takeda Pharmaceuticals USA had sued Amneal in the U.S. District Court for the District of Delaware over the drug Colcrys (colchicine), used to treat gout and familial Mediterranean fever.

  • FDA approves Lundbeck's Sabril in children

    DEERFIELD, Ill. — The Food and Drug Administration has approved a drug made by Lundbeck for treating a form of epilepsy in children, the drug maker said.

    Lundbeck announced the approval of Sabril (vigabatrin) as an add-on therapy for refractory complex partial seizures in children ages 10 years and older who have not responded adequately to other treatments, as long as the benefit of treatment outweighs the risk of vision loss. The drug was already approved for treating the same condition in adults in 2009.

  • Depomed launches Lazanda nasal spray for breakthrough pain in cancer patients

    NEWARK, Calif. — Depomed has launched a new drug for breakthrough pain in cancer patients, the company said Monday.

    The drug maker announced the launch of Lazanda (fentanyl) nasal spray, meant for treating adults who are taking opioid painkillers, but have become tolerant to them. The company also have launched a Signature Support Program designed to streamline patient access to the drug, including reimbursement and co-pay assistance. Other benefits of the program include prescription reminders and eligibility for one month's supply for free.

  • Logitech launches iPad Air accessories line

    NEWARK, Calif. — Logitech has introduced a line of accessories for Apple's new iPad Air, the electronics maker said.

    The line includes the FabricSkin Keyboard Folio, the Ultrathin Keyboard Cover, the Ultrathin Keyboard Folio and the Folio Protective Case, all designed to protect against bumps, scratches and spills while remaining thin and light.

  • Blistex launches new lip balms

    OAK BROOK, Ill. — Blistex expanded its product portfolio in October with the launch of two new lip balms — Nurture and Nourish and Lip Vibrance.

X
This ad will auto-close in 10 seconds